Concomitant Pancreatic Activation of KrasG12D and Tgfa Results in Cystic Papillary Neoplasms Reminiscent of Human IPMN

Cancer Cell

Volumn 12, Issue 3, 2007, Pages 266-279

  Siveke, Jens T ^a   Einwächter, Henrik ^a   Sipos, Bence ^b   Lubeseder Martellato, Clara ^a   Klöppel, Günter ^b   Schmid, Roland M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

CELLCYCLE

Indexed keywords

ELASTASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN P48; STAT3 PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; KRAS GENE; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PANCREAS ADENOMA; PANCREAS CANCER; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

MUS;

EID: 34548205213     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.08.002     Document Type: Article

References (50)

1. Adsay N.V., Merati K., Andea A., Sarkar F., Hruban R.H., Wilentz R.E., Goggins M., Iocobuzio-Donahue C., Longnecker D.S., and Klimstra D.S. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod. Pathol. 15 (2002) 1087-1095
2. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., and DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17 (2003) 3112-3126
3. Allison D.C., Piantadosi S., Hruban R.H., Dooley W.C., Fishman E.K., Yeo C.J., Lillemoe K.D., Pitt H.A., Lin P., and Cameron J.L. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J. Surg. Oncol. 67 (1998) 151-159
4. Bardeesy N., Aguirre A.J., Chu G.C., Cheng K.H., Lopez L.V., Hezel A.F., Feng B., Brennan C., Weissleder R., Mahmood U., et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 103 (2006) 5947-5952
5. Bardeesy N., Cheng K.H., Berger J.H., Chu G.C., Pahler J., Olson P., Hezel A.F., Horner J., Lauwers G.Y., Hanahan D., and Depinho R.A. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20 (2006) 3130-3146
6. Bardeesy N., Morgan J., Sinha M., Signoretti S., Srivastava S., Loda M., Merlino G., and DePinho R.A. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol. Cell. Biol. 22 (2002) 635-643
7. Barton C.M., Hall P.A., Hughes C.M., Gullick W.J., and Lemoine N.R. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J. Pathol. 163 (1991) 111-116
8. Biankin A.V., Biankin S.A., Kench J.G., Morey A.L., Lee C.S., Head D.R., Eckstein R.P., Hugh T.B., Henshall S.M., and Sutherland R.L. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut 50 (2002) 861-868
9. Biankin A.V., Kench J.G., Biankin S.A., Lee C.S., Morey A.L., Dijkman F.P., Coleman M.J., Sutherland R.L., and Henshall S.M. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: Implications for disease progression and recurrence. Am. J. Surg. Pathol. 28 (2004) 1184-1192
10. Brugge W.R., Lauwers G.Y., Sahani D., Fernandez-del Castillo C., and Warshaw A.L. Cystic neoplasms of the pancreas. N. Engl. J. Med. 351 (2004) 1218-1226
11. Canto M.I., Goggins M., Hruban R.H., Petersen G.M., Giardiello F.M., Yeo C., Fishman E.K., Brune K., Axilbund J., Griffin C., et al. Screening for early pancreatic neoplasia in high-risk individuals: A prospective controlled study. Clin. Gastroenterol. Hepatol. 4 (2006) 766-781 quiz 665
12. Friess H., Guo X.Z., Nan B.C., Kleeff O., and Buchler M.W. Growth factors and cytokines in pancreatic carcinogenesis. Ann. N Y Acad. Sci. 880 (1999) 110-121
13. Furukawa T., Kloppel G., Volkan Adsay N., Albores-Saavedra J., Fukushima N., Horii A., Hruban R.H., Kato Y., Klimstra D.S., Longnecker D.S., et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch. 447 (2005) 794-799
14. Greten F.R., Weber C.K., Greten T.F., Schneider G., Wagner M., Adler G., and Schmid R.M. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 123 (2002) 2052-2063
15. Grippo P.J., Nowlin P.S., Demeure M.J., Longnecker D.S., and Sandgren E.P. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res. 63 (2003) 2016-2019
16. Gu G., Dubauskaite J., and Melton D.A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129 (2002) 2447-2457
17. Guerra C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., and Barbacid M. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4 (2003) 111-120
18. Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., and Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 20 (2006) 1218-1249
19. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4 (2003) 437-450
20. Hingorani S.R., Wang L., Multani A.S., Combs C., Deramaudt T.B., Hruban R.H., Rustgi A.K., Chang S., and Tuveson D.A. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7 (2005) 469-483
21. Hruban R.H., Adsay N.V., Albores-Saavedra J., Anver M.R., Biankin A.V., Boivin G.P., Furth E.E., Furukawa T., Klein A., Klimstra D.S., et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations. Cancer Res. 66 (2006) 95-106
22. Hruban R.H., Takaori K., Klimstra D.S., Adsay N.V., Albores-Saavedra J., Biankin A.V., Biankin S.A., Compton C., Fukushima N., Furukawa T., et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28 (2004) 977-987
23. Izeradjene K., Combs C., Best M., Gopinathan A., Wagner A., Grady W.M., Deng C.X., Hruban R.H., Adsay N.V., Tuveson D.A., and Hingorani S.R. Kras(G12D) and Smad4/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas. Cancer Cell 11 (2007) 229-243
24. Kawaguchi Y., Cooper B., Gannon M., Ray M., MacDonald R.J., and Wright C.V. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32 (2002) 128-134
25. Kosmahl M., Pauser U., Peters K., Sipos B., Luttges J., Kremer B., and Kloppel G. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: A review of 418 cases and a classification proposal. Virchows Arch. 445 (2004) 168-178
26. Luttges J., Zamboni G., Longnecker D., and Kloppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am. J. Surg. Pathol. 25 (2001) 942-948
27. Maitra A., Fukushima N., Takaori K., and Hruban R.H. Precursors to invasive pancreatic cancer. Adv. Anat. Pathol. 12 (2005) 81-91
28. Miyamoto Y., Maitra A., Ghosh B., Zechner U., Argani P., Iacobuzio-Donahue C.A., Sriuranpong V., Iso T., Meszoely I.M., Wolfe M.S., et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3 (2003) 565-576
29. Miyatsuka T., Kaneto H., Shiraiwa T., Matsuoka T.A., Yamamoto K., Kato K., Nakamura Y., Akira S., Takeda K., Kajimoto Y., et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 20 (2006) 1435-1440
30. Muller-Decker K., Furstenberger G., Annan N., Kucher D., Pohl-Arnold A., Steinbauer B., Esposito I., Chiblak S., Friess H., Schirmacher P., and Berger I. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Gastroenterology 130 (2006) 2165-2178
31. Nakhai H., Sel S., Favor J., Mendoza-Torres L., Paulsen F., Duncker G.I., and Schmid R.M. Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina. Development 134 (2007) 1151-1160
32. Ohuchida K., Mizumoto K., Fujita H., Yamaguchi H., Konomi H., Nagai E., Yamaguchi K., Tsuneyoshi M., and Tanaka M. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: Clinical implications of mRNA levels in pancreatic juice. J. Pathol. 210 (2006) 42-48
33. Pasca di Magliano M., Sekine S., Ermilov A., Ferris J., Dlugosz A.A., and Hebrok M. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 20 (2006) 3161-3173
34. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., Pergamenschikov A., Williams C.F., Zhu S.X., Lee J.C., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96 (1999) 9212-9217
35. Prasad N.B., Biankin A.V., Fukushima N., Maitra A., Dhara S., Elkahloun A.G., Hruban R.H., Goggins M., and Leach S.D. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 65 (2005) 1619-1626
36. Sandgren E.P., Luetteke N.C., Palmiter R.D., Brinster R.L., and Lee D.C. Overexpression of TGF alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61 (1990) 1121-1135
37. Sato N., Fukushima N., Maitra A., Iacobuzio-Donahue C.A., van Heek N.T., Cameron J.L., Yeo C.J., Hruban R.H., and Goggins M. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am. J. Pathol. 164 (2004) 903-914
38. Schneider G., Siveke J.T., Eckel F., and Schmid R.M. Pancreatic cancer: Basic and clinical aspects. Gastroenterology 128 (2005) 1606-1625
39. Siveke J.T., and Schmid R.M. Chromosomal instability in mouse metastatic pancreatic cancer-it's Kras and Tp53 after all. Cancer Cell 7 (2005) 405-407
40. Stanger B.Z., Stiles B., Lauwers G.Y., Bardeesy N., Mendoza M., Wang Y., Greenwood A., Cheng K.H., McLaughlin M., Brown D., et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8 (2005) 185-195
41. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
42. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425 (2003) 851-856
43. Tuveson D.A., Zhu L., Gopinathan A., Willis N.A., Kachatrian L., Grochow R., Pin C.L., Mitin N.Y., Taparowsky E.J., Gimotty P.A., et al. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res. 66 (2006) 242-247
44. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J. Hepatobiliary Pancreat. Surg. 9 (2002) 76-85
45. Wagner M., Greten F.R., Weber C.K., Koschnick S., Mattfeldt T., Deppert W., Kern H., Adler G., and Schmid R.M. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev. 15 (2001) 286-293
46. Wagner M., Luhrs H., Kloppel G., Adler G., and Schmid R.M. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115 (1998) 1254-1262
47. Warshaw A.L., and Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326 (1992) 455-465
48. Whitfield M.L., George L.K., Grant G.D., and Perou C.M. Common markers of proliferation. Nat. Rev. Cancer 6 (2006) 99-106
49. Yeh T.S., Jan Y.Y., Chiu C.T., Ho Y.B., Chen T.C., Lee K.F., Chan K.M., Hsu J.C., Hwang T.L., and Chen M.F. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma. Gut 51 (2002) 712-716
50. Yeh T.S., Tseng J.H., Liu N.J., Chen T.C., Jan Y.Y., and Chen M.F. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch. Surg. 140 (2005) 1184-1190